Rifaximin as treatment for hepatic encephalopathy: some considerations.
作者信息
Ridola Lorenzo, Zullo Angelo, Hassan Cesare
出版信息
Saudi J Gastroenterol. 2013 Jan-Feb;19(1):56. doi: 10.4103/1319-3767.105930.
Abstract
摘要
相似文献
1
Rifaximin as treatment for hepatic encephalopathy: some considerations.利福昔明治疗肝性脑病：一些思考。
Saudi J Gastroenterol. 2013 Jan-Feb;19(1):56. doi: 10.4103/1319-3767.105930.
2
Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.综述文章：利福昔明治疗肝性脑病和肝硬化其他并发症的作用机制。
Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:11-26. doi: 10.1111/apt.13435.
3
Hepatic encephalopathy.肝性脑病。
Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123.
4
ABC of diseases of liver, pancreas, and biliary system: portal hypertension-2. Ascites, encephalopathy, and other conditions.肝脏、胰腺及胆道系统疾病基础知识：门静脉高压症-2. 腹水、肝性脑病及其他情况。
BMJ. 2001 Feb 17;322(7283):416-8. doi: 10.1136/bmj.322.7283.416.
5
Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.雷洛昔芬对肝硬化大鼠门静脉高压和肝性脑病的影响。
Eur J Pharmacol. 2017 May 5;802:36-43. doi: 10.1016/j.ejphar.2017.02.039. Epub 2017 Feb 24.
6
Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension.非出血性急性并发症与肝硬化和门静脉高压相关。
Best Pract Res Clin Gastroenterol. 2013 Oct;27(5):665-78. doi: 10.1016/j.bpg.2013.08.005. Epub 2013 Sep 5.
7
[Hepatic encephalopathy in surgical treatment of patients with portal hypertension].[门静脉高压症患者外科治疗中的肝性脑病]
Klin Med (Mosk). 1995;73(2):37-9.
8
[Evaluation of the functional state of the liver in cirrhosis and extrahepatic portal hypertension].
Khirurgiia (Mosk). 1975 Jan(1):56-62.
9
[Disorders of amino-acid balance in patients with portal encephalopathy].
Pol Arch Med Wewn. 1983 Jan;69(1):29-36.
10
Future Therapies of Hepatic Encephalopathy.肝性脑病的未来治疗方法。
Clin Liver Dis. 2024 May;28(2):331-344. doi: 10.1016/j.cld.2024.02.002.
本文引用的文献
1
Hepatic encephalopathy.肝性脑病。
Saudi J Gastroenterol. 2012 Sep-Oct;18(5):301-9. doi: 10.4103/1319-3767.101123.
2
Rifaximin therapy and hepatic encephalopathy: Pros and cons.利福昔明治疗与肝性脑病：利弊
World J Gastrointest Pharmacol Ther. 2012 Aug 6;3(4):62-7. doi: 10.4292/wjgpt.v3.i4.62.
3
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝性脑病。
Clin Liver Dis. 2012 Feb;16(1):133-46. doi: 10.1016/j.cld.2011.12.008. Epub 2012 Jan 4.
4
Rifaximin for the treatment of hepatic encephalopathy.利福昔明用于治疗肝性脑病。
Pharmacotherapy. 2008 Aug;28(8):1019-32. doi: 10.1592/phco.28.8.1019.
5
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.经颈静脉肝内门体分流术后肝性脑病的药物预防：一项随机对照研究
J Hepatol. 2005 May;42(5):674-9. doi: 10.1016/j.jhep.2004.12.028.
Zotero 插件